This inventor holds 1 USPTO granted patent. Top assignee: Bristol-Myers Squibb Compnay. Active years: 1997.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1997
Title: Susan L. Gawlak: Innovator in Ribosome-Inactivating Proteins
Introduction
Susan L. Gawlak is a notable inventor based in Bellevue, WA (US). She has made significant contributions to the field of biochemistry, particularly in the study of ribosome-inactivating proteins. Her work has implications for various medical applications, including cancer treatment and immunotherapy.
Latest Patents
Susan L. Gawlak holds a patent for her invention titled "Bryodin 2," which is a ribosome-inactivating protein isolated from the plant Bryonia dioica. This innovative protein is classified as a type I ribosome-inactivating protein (RIP) and features a single polypeptide chain without a cellular receptor domain. Bryodin 2 has a molecular weight of approximately 27,000 daltons and a pI of 9.5. It is distinguished from previously identified ribosome-inactivating proteins by its unique amino acid composition, sequence, and varying toxicity in vitro and in vivo. The applications of Bryodin 2 are promising, as it can serve as an abortifacient, immunomodulator, and anti-tumor or anti-viral agent. Additionally, compositions that incorporate Bryodin 2 as an immunoconjugate or fusion molecule are particularly effective in targeting and killing specific cell populations.
Career Highlights
Susan L. Gawlak is currently associated with Bristol-Myers Squibb Company, where she continues her research and development efforts. Her work has been instrumental in advancing the understanding of ribosome-inactivating proteins and their potential therapeutic uses.
Collaborations
Throughout her career, Susan has collaborated with esteemed colleagues, including Clay B. Siegall and Hans Marquardt. These collaborations have further enriched her research and contributed to the advancement of knowledge in her field.
Conclusion
Susan L. Gawlak is a pioneering inventor whose work on Bryodin 2 has opened new avenues in the field of biochemistry and medicine. Her contributions are vital for the development of innovative therapeutic strategies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile